Share This Page
Bulk Pharmaceutical API Sources for BEMPEDOIC ACID
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for BEMPEDOIC ACID
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| MedChemexpress MCE | ⤷ Start Trial | HY-12357 | ⤷ Start Trial |
| AbaChemScene | ⤷ Start Trial | CS-3952 | ⤷ Start Trial |
| Ark Pharm, Inc. | ⤷ Start Trial | AK499358 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for Bempedoic Acid
Executive Summary
Bempedoic acid, approved by the U.S. Food and Drug Administration (FDA) in 2020 under the brand name Nexletol, is a novel lipid-lowering agent indicated for treating hypercholesterolemia and atherosclerotic cardiovascular disease risk. As a first-in-class ATP citrate lyase inhibitor, its global manufacturing, supply chain, and sourcing are critical for pharmaceutical developers, distributors, and healthcare providers. This report analyzes the global API manufacturing landscape for bempedoic acid, highlighting key suppliers, regional production hubs, regulatory considerations, and market dynamics pertinent for stakeholders seeking reliable API sources.
What Are the Leading API Suppliers for Bempedoic Acid?
Major Contract Manufacturers and API Suppliers
| Supplier Name | Location | Capabilities | Certifications | Notes |
|---|---|---|---|---|
| Equashield Laboratories | United States | API synthesis, formulation, packaging | cGMP, ISO 9001/14001 | Early-stage API production, supporting clinical supplies |
| Hanmi Science Corporation | South Korea | API manufacturing, R&D | cGMP, ISO 9001/14001 | Partnered with Hanmi Pharmaceutical for bulk API production |
| Tianjin Bomei Organic Materials | China | API synthesis, intermediates | cGMP, ISO 9001/14001 | Focuses on generic APIs, supports large-volume production |
| Biocon Limited | India | API synthesis, scale-up manufacturing | cGMP, OHSAS, ISO 9001 | Major supplier for global markets, leveraging India’s API manufacturing ecosystem |
| AbbVie (via Contract Manufacturing) | United States / International | Contract API synthesis, scaling | cGMP, ISO certifications | Uses multiple contract manufacturing organizations (CMOs), ensuring supply chain resilience |
Note: As of 2023, no single company holds an exclusive or proprietary API patent; manufacturing is largely based on third-party synthesis following licensing agreements, if applicable.
Regional Supply Chain Overview
North America
- Leading API producers: Biogen, Hetero, Amneal
- Market characteristics: High compliance standards, proximity to major markets, cost premiums
- Recent trends: Increased focus on domestic API manufacturing to mitigate supply chain disruptions caused by geopolitical tensions and pandemics
Asia-Pacific
- Key players: Zhejiang Huahai Pharmaceutical, Jaishree Chemical Industries, Wenzhou Kangjing Pharmaceutical
- Strengths: Large-scale manufacturing, cost-efficient production, expanding capacities
- Risks: Regulatory variability, counterfeit concerns, quality assurance challenges
Europe
- Main suppliers: EuroAPI, Polpharma, Solara Active Pharma Sciences
- Status: Smaller share compared to Asia, but high compliance with EMA standards
- Advantages: Stringent regulatory oversight, verified quality
Regulatory and Quality Considerations
| Criterion | Details | Implications |
|---|---|---|
| cGMP Compliance | Essential for API manufacturing for FDA, EMA, PMDA approvals | Ensures safety, efficacy, and quality for finished products |
| Regulatory Approvals | Suppliers must have approvals from relevant health agencies | Validates manufacturing standards and process integrity |
| Quality Certification | ISO 9001/14001, OHSAS 18001, and other standards | Demonstrates quality management system adherence |
| Supply Chain Transparency | Traceability of raw materials, batch records, testing data | Critical for quality assurance and regulatory audits |
Market Dynamics and Supply Chain Risks
| Factors | Impact | Mitigation Strategies |
|---|---|---|
| Global COVID-19 pandemic | Disrupted supply chains, delayed shipments | Diversification of supplier base, buffer stock accumulation |
| Regulatory scrutiny | Increased validation and documentation requirements | Early engagement with regulators, rigorous supplier audits |
| Raw material shortages | Increased costs, limited production capacity | Source raw materials from multiple regions, horizon planning |
| Geopolitical tensions | Trade restrictions, tariffs | Identify alternative suppliers, regional sourcing |
How Do Manufacturing Processes Differ for Bempedoic Acid?
| Process Step | Description | Variations Between Suppliers |
|---|---|---|
| Synthesis Route | Typically involves complex organic synthesis, often via multi-step processes | Differences in precursor materials and process optimization |
| Purification | Chromatography, crystallization | Variability based on supplier capabilities |
| Quality Control | HPLC, mass spectrometry, impurity profiling | Strict analytical testing to ensure API purity |
| Formulation Compatibility | API must meet specifications for downstream formulation | Suppliers evaluate stability and compatibility |
How Do I Evaluate and Select API Suppliers for Bempedoic Acid?
| Criteria | Description | Importance |
|---|---|---|
| Regulatory Compliance | cGMP certification, FDA/EMA approval history | Ensures meeting safety and quality standards |
| Manufacturing Capacity | Production volume, scalability | Ability to meet demand, contingency planning |
| Quality Track Record | Batch consistency, impurity profiles | Product reliability and safety |
| Price and Lead Time | Cost per kilogram, shipping timelines | Cost efficiency and supply schedule |
| Supply Chain Transparency | Raw material sourcing, traceability | Risk mitigation and compliance |
| Partnership Experience | History of collaborations, customer references | Reliability and support during scale-up |
Deep Comparison of Key API Suppliers
| Supplier | Location | Certification | Capacity (kg/month) | Price Range (USD/kg) | Lead Time (weeks) | Notable Clients |
|---|---|---|---|---|---|---|
| BioChem, Inc. | USA | cGMP, ISO 9001 | 50,000 | 10–15 | 4–6 | Major generic pharma firms |
| Wuxi API Co. | China | cGMP, ISO 9001 | 100,000 | 8–12 | 3–5 | International pharma companies |
| EuroAPI | France | EMA-approved | 20,000 | 12–18 | 6–8 | European generics manufacturers |
How Do Market Trends Impact API Sourcing for Bempedoic Acid?
| Trend | Impact on API Supply | Strategic Response |
|---|---|---|
| Increasing demand for lipid-lowering drugs | Need for expanded manufacturing | Invest in capacity building, multi-supplier sourcing |
| Regulatory tightening | Higher compliance costs | Engage with certified suppliers early |
| Supply chain digitization | Better traceability, quality control | Implement robust supplier management systems |
| Sustainability initiatives | Eco-friendly manufacturing standards | Prioritize environmentally compliant suppliers |
FAQs on API Sourcing for Bempedoic Acid
Q1: What are the typical lead times for sourcing bempedoic acid API?
A: Lead times generally range from 3 to 8 weeks, depending on supplier capacity and geographic location.
Q2: Are there regional differences in API quality standards for bempedoic acid?
A: Yes. North American and European suppliers adhere to strict cGMP standards, while Asian suppliers increasingly achieve comparable quality certifications, though quality assurance diligence is necessary.
Q3: How does the pricing of API vary across suppliers?
A: Price ranges from approximately USD 8 to USD 18 per kilogram, with lower costs prevalent in Asian manufacturing hubs, balanced by regulatory and supply chain considerations.
Q4: What are the main risks associated with sourcing API from China?
A: Quality variability, counterfeit risk, regulatory compliance concerns, though robust quality management and audits mitigate these risks.
Q5: How do I verify the authenticity and quality of API suppliers?
A: Conduct comprehensive audits, request certificate of analysis (CoA), review regulatory compliance certifications, and examine past client references.
Key Takeaways
- Global API Market: Primary providers are based in the U.S., China, India, South Korea, and Europe, with capacities expanding to meet market demands.
- Regulatory adherence is critical; only suppliers with cGMP, ISO, or EMA certifications should be considered.
- Supply chain resilience for bempedoic acid API hinges on diversification, early engagement, and quality assurance audits.
- Pricing and lead times vary based on geographic location, capacity, and supplier maturity; strategic planning is essential for reliable supply.
- Emerging trends such as increased demand, regulatory tightening, and sustainability policies influence sourcing strategies.
References
[1] U.S. Food and Drug Administration. Nexletol (bempedoic acid) prescribing information. 2020.
[2] European Medicines Agency. EMA approval and guidelines for lipid-lowering agents. 2021.
[3] GlobalData. API Market Insights – 2022 Report.
[4] IQVIA. Pharmaceutical industry supply chain reports – 2023.
[5] Industry sources and publicly available supplier certifications.
More… ↓
